Matched cohort study reveals increased insomnia medication initiation due to COVID-19, indicating a need for mental health support.
COVID-19 significantly associates with an elevated risk of insomnia medication initiation, emphasizing the necessity for mental health support in post-COVID-19 care. This study offers insights into the pandemic's influence on pharmacological treatment practices.
No takes yet. Share an insight, caveat, or question.
Miyamori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: